BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
PRKCA
,
G-protein-coupled receptor binding
,
Lung cancer
,
Heart
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
avian flu
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
IFNA1
IFNA16
IFNB1
IFNA2
MAFB
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
heterocyclic compound binding
organic cyclic compound binding
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Macrophages infection with avian influenza viruses of low and high pathogenicity
HUVEC cells HPAIV H7N7 infected and/or p38-inhibitor SB 202190 treated
Primary monocytes infected with high or low pathogenicity influenza viruses
Calu-3 cells after influenza H3N2 and H11N9 infection
Explore Curated Studies Results
Literature
Most Relevant Literature
Characterization of H3 subtype avian influenza viruses isolated from poultry in Vietnam.
Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus.
Mutations in PB2 and HA enhanced pathogenicity of H4N6 avian influenza virus in mice.
The Evolution, Spread and Global Threat of H6Nx Avian Influenza Viruses.
Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Development of Immune Globulin Treatment for Avian Flu
Safety Study of Avian Flu Vaccine
T and B Cell Response to Avian Flu Vaccine
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ